Zhanguo Zhang

13PUBLICATIONS
12CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical devicesCancer cell biologyCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 10, 2025
VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization.

Chen Su, Zhibin Liao, Jie Mo

|Jul 31, 2025
Targeting Aurora kinase B regulates cholesterol metabolism and enhances chemoimmunotherapy in cholangiocarcinoma.

Furong Liu, Wei Chen, Ze Zhang

|Mar 21, 2025
Hafnium Metal-Organic Framework-Based Glutamine Metabolism Disruptor For Potentiating Radio-Immunotherapy in MYC-Amplified Hepatocellular Carcinoma.

Haofan Hu, Shangwu Ning, Furong Liu

|Sep 05, 2024
m6A-Dependent ITIH1 Regulated by TGF-β Acts as a Target for Hepatocellular Carcinoma Progression.

Zhibin Liao, Hongwei Zhang, Furong Liu

|Oct 13, 2023
MYC in liver cancer: mechanisms and targeted therapy opportunities.

Furong Liu, Zhibin Liao, Zhanguo Zhang

|Apr 28, 2023
Collagen I-DDR1 signaling promotes hepatocellular carcinoma cell stemness via Hippo signaling repression.

Yi-Xiao Xiong, Xiao-Chao Zhang, Jing-Han Zhu

Pageof 3

Frequent Collaborators

3 joint publications

Bixiang Zhang

2 joint publications

Huifang Liang

2 joint publications

Zhibin Liao

1 joint publications

Yi-Xiao Xiong